Cizzle Bio, Inc.
banner
cizzlebio.com
Cizzle Bio, Inc.
@cizzlebio.com
🔬 Detect Early. Save Lives.
Cizzle Bio, Inc. is a biotech company pioneering early cancer detection through advanced blood tests for lung & GI cancers.
cizzlebio.com
New blog: earlier cancer detection is pushing survival to new highs. Read the full post here:
Earlier Cancer Detection Is Boosting Cancer Survival Rates | Cizzle Bio, Inc.
New American Cancer Society data shows 70% of U.S. cancer patients now survive at least five years. Learn what’s driving progress and why earlier detection matters.
buff.ly
February 13, 2026 at 12:04 AM
Early detection starts with a conversation. Ask about screening and follow-up.
#ScreeningMatters #EarlyDetection #CancerAwareness
February 6, 2026 at 11:28 PM
National Cancer Awareness Month: we’re advancing the DEX-G2 biomarker blood test, designed to support gastric cancer detection with a minimally invasive blood draw.
#CancerAwarenessMonth #EarlyDetection #GastricCancer #Biomarkers
February 6, 2026 at 12:04 AM
World Cancer Day: United by Unique. People first, always.
#WorldCancerDay #UnitedByUnique #DetectEarlySaveLives
February 5, 2026 at 12:55 AM
Anyone can develop lung cancer — even those who’ve never smoked.
From radon to air pollution, hidden risks matter.
Learn what causes lung cancer in non-smokers and how early detection saves lives.
🔗 Read more: buff.ly/20s2nyY
#LungCancerAwareness #EarlyDetection #CizzleBio
Can Anyone Develop Lung Cancer? Understanding Risks Beyond Smoking | Cizzle Bio, Inc.
Lung cancer can affect anyone, even non-smokers. Learn about hidden risks and how early detection with CIZ1B can save lives.
www.cizzlebio.com
October 10, 2025 at 4:04 PM
Cizzle Bio is attending #AVBCC2025 in NYC! 🗽 Our CEO, Bill Behnke, will moderate: “Advancing Cancer Diagnostics to Commercialization”—a panel exploring the pathway of delivering innovative diagnostics in value-based care.
🗓️ Oct 22–24 📍 New York Athletic Club 🔗 buff.ly/wtq6ujH
#CizzleBio #Biotech
Cizzle Bio to Attend and Moderate at 2025 AVBCC Summit in NYC | Cizzle Bio, Inc.
Join Cizzle Bio at the 15th Annual AVBCC Summit in New York City, Oct 22–24, 2025. CEO Bill Behnke will moderate a panel on commercializing cancer diagnostics.
www.cizzlebio.com
October 7, 2025 at 7:48 PM
Too young for lung cancer? The truth may surprise you. Rates are rising among younger adults; many never smoked. Learn why awareness and early detection with the CIZ1B biomarker blood test are critical.
🔗 Read more: buff.ly/ZWbnQ1H
#EarlyDetection #LungCancerAwareness #CizzleBio
October 3, 2025 at 4:04 PM
Excited to share that Cizzle Bio is attending the Global Cancer Research and Innovation Symposium on October 21 in NYC! We’ll be engaging with industry leaders to discuss our CIZ1B and DEX-G2 blood tests for early cancer detection. 🔗 buff.ly/d3cqA8z #CizzleBio #GCRIS2025 #Biotech #CancerResearch
Cizzle Bio to Attend Global Cancer Research & Innovation Symposium 2025 | Cizzle Bio, Inc.
Cizzle Bio will attend the inaugural Global Cancer Research and Innovation Symposium on October 21, 2025, in New York City—engaging with leaders in oncology, biotech, and early detection.
www.cizzlebio.com
September 26, 2025 at 7:37 PM
🌍 It’s World Lung Day.
At Cizzle Bio, we’re advancing blood tests that detect lung cancer early—when survival rates are highest. 💚
Together, let’s make early detection the standard of care.#WorldLungDay #DetectEarlySaveLives #CizzleBio #medsky
September 25, 2025 at 7:57 PM
🌍 Today is #WorldCancerResearchDay.
We stand with researchers worldwide advancing cancer prevention, detection & treatment. At Cizzle Bio, we’re focused on early detection through biomarker science—because finding cancer early saves lives. 💚💙
#EarlyDetectionMatters #CizzleBio
September 24, 2025 at 6:49 PM
We’re featured in Chief’s Digest!
The article highlights how we’re transforming cancer detection with biomarker-based blood tests for early lung & gastric cancer detection.
Read it here: buff.ly/aC1mc77
#DetectEarlySaveLives #CancerPrevention
Cizzle Bio, Inc.: Transforming Cancer Detection Through Precision and Purpose - The Chief Digest
Website: www.cizzlebio.com Founding Year: 2024 Office Locations: San Antonio, Texas (HQ), with partnerships across the United States, the UK, and the Caribbean In a world where cancer remains a…
thechiefsdigest.com
September 24, 2025 at 4:47 PM
📢 New Press Release:
Cizzle Bio sponsored the Prevent Cancer Foundation® 40th Anniversary and Gala.
Read how this milestone event reinforces our mission to make early detection the global standard of care.
🔗 buff.ly/QpLwpRd
#DetectEarlySaveLives #CancerPrevention
September 23, 2025 at 4:24 PM
Thank you @preventcancer.org for uniting such an inspiring community at this year’s Gala. We’re proud to sponsor and advance early detection with two simple blood tests – CIZ1B (lung) & DEX-G2 (gastric).

#DetectEarlySaveLives #PreventCancerGala
@inovahealth.bsky.social @lungevity.bsky.social
September 19, 2025 at 4:48 PM
A night to remember at the @preventcancer.org Foundation® 40th Anniversary Gala ✨ Proud to celebrate innovation with leaders in research, advocacy & patient care - all united by one goal: early detection saves lives.

#DetectEarlySaveLives #PreventCancerGala
September 18, 2025 at 11:57 PM
We’re proud to support the @preventcancer.org Foundation® 40th Anniversary Gala - a powerful reminder that early detection saves lives.

CIZ1B: early lung cancer detection
DEX-G2: early gastric cancer detection

#DetectEarlySaveLives #PreventCancerGala
September 18, 2025 at 5:32 PM
Did you know radon gas is the 2nd leading cause of lung cancer in the U.S.?
It’s invisible, odorless—and preventable. Testing your home can reduce risks and save lives.
Read our new blog to learn more:
How Radon Raises Lung Cancer Risk - What to Know | Cizzle Bio, Inc.
Radon is colorless and odorless yet the second leading cause of lung cancer. Learn how radon forms, why testing matters, EPA action levels, and steps to reduce risk.
www.cizzlebio.com
September 17, 2025 at 11:55 PM
Exciting news: Dr. Mark Miglarese has joined Cizzle Bio as Senior Lab Advisor! With decades of leadership in oncology R&D and diagnostics, his expertise strengthens our mission to detect cancer early.
Read more: buff.ly/Oq6ZpPp
#CizzleBio #CancerResearch #EarlyDetection
September 16, 2025 at 9:47 PM
Cizzle Bio is attending CHEST 2025 Annual Meeting in Chicago, Oct 19–22.
This 90th anniversary event brings together the world’s top pulmonary and critical care experts. We’re proud to highlight CIZ1B, our blood test for early lung cancer detection (95% sensitivity, 96% NPV).
buff.ly/BstOadd
Cizzle Bio to Attend CHEST 2025 Annual Meeting in Chicago | Cizzle Bio, Inc.
Cizzle Bio will attend CHEST 2025 in Chicago, Oct 19–22, joining pulmonary and critical care leaders. Our presence reflects our commitment to advancing early lung cancer detection with the CIZ1B…
www.cizzlebio.com
September 11, 2025 at 11:04 PM
Medical oncologist and clinical researcher Jessica Treviño Jones, M.D., is reshaping how and when we detect lung cancer.
In a new blog with @CizzleBio, she explains why CIZ1B—a true biomarker test—offers a chance to catch cancer earlier when treatment is most effective.
buff.ly/ARpC5l0
The Power of Early Detection: Dr. Jessica Trevino Jones on CIZ1B Lung Cancer Biomarker | Cizzle Bio, Inc.
Oncologist Dr. Jessica Trevino Jones shares how Cizzle Bio’s CIZ1B biomarker blood test could transform early lung cancer detection, prevention, and patient outcomes.
www.cizzlebio.com
September 10, 2025 at 9:33 PM
Cizzle Bio is proud to sponsor the @preventcancer.org, celebrating progress in early detection.
Our blood tests (CIZ1B & DEX-G2) detect cancer early, when it’s most treatable.
Learn more: www.cizzlebio.com
#PreventCancerGala #EarlyDetection
September 8, 2025 at 8:46 PM
Drea was told: “You’re too young for lung cancer.”

She was 26.

She had Stage 4 — in both lungs, her spine, and brain.

🫁 Lung cancer is the #1 cancer killer — and it’s rising in women under 50.

We must listen. We must detect early.

#CizzleBio #LungCancerAwareness #GenerationCancer
August 19, 2025 at 6:46 PM
Cizzle Bio is proud to attend the 8th Annual AABIP Conference this August in Austin, TX.
We’ll be engaging with leaders in pulmonology to discuss how our CIZ1B and DEX-G2 blood tests support early, accurate, and minimally invasive cancer detection.
🔗 buff.ly/foAKcMO
Cizzle Bio to Attend AABIP 2025 in Austin, TX – Advancing Early Detection | Cizzle Bio, Inc.
Cizzle Bio will attend AABIP 2025 on August 14–16 in Austin, TX to network with leaders in bronchoscopy and discuss early detection innovations like CIZ1B and DEX-G2.
www.cizzlebio.com
August 8, 2025 at 8:43 PM
Published in JAMA Surgery
Our DEX-G2 biomarker-based blood test shows 95% sensitivity and 96.8% accuracy for early gastric cancer detection.
Validated across 809 samples in a major international study.
🔗 Read more: buff.ly/p8dnXQL
#DEXG2 #EarlyDetection #CizzleBio
August 5, 2025 at 6:35 PM
This #WorldLungCancerDay, we reaffirm our mission:
Make early lung cancer detection accessible and affordable.
CIZ1B is coming.
Follow our journey. #CizzleBio #EarlyDetection
August 1, 2025 at 11:30 PM
Lung cancer survival drops from 60% at Stage I to just 7% at Stage IV.
Our CIZ1B blood test aims to catch it early—when it matters most.
#WorldLungCancerDay #FightLungCancer #CizzleBio
August 1, 2025 at 9:30 PM